Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel zinc finger protein pseudogene (ENSG00000268892, also known as AC010620.1) is a human pseudogene likely derived from ancestral zinc finger protein-coding genes. Pseudogenes are genomic DNA sequences similar to normal genes but usually non-functional due to mutations or lack of regulatory elements. Zinc finger proteins are a large, diverse group of DNA-binding proteins involved in transcriptional regulation and various cellular processes, but this pseudogene does not produce a functional protein and is not currently thought to play a direct role in physiology or disease[1][2][3][4]. While zinc finger proteins as a family are widespread, highly functional, and implicated in many processes including transcriptional regulation, DNA repair, cancer, and genome editing, this entry encodes a pseudogene that does not give rise to an active zinc finger protein[1][2][4]. Therefore, ENSG00000268892 should not be considered a therapeutic target, functional receptor, or active enzyme and does not have structured data comparable to canonical drug targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel zinc finger protein pseudogene (ENSG00000268892).